Hard to figure what Wall Street wants. | BMY Message Board Posts

Bristol-Myers Squibb Co.

  BMY website

BMY   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  4314 of 4724  at  9/25/2020 8:21:31 AM  by

Doolen


Hard to figure what Wall Street wants.

The amount of risk  mitigation in BMY earnings going forward over the last six months is almost unbelievable in light of the $5 plus per share drop since mid summer. 
 
I  know one can't fight total market moves, the Fed, etc., but at some point, the PPS has to reflect the real world promise.
 
The Company:
 
- has 25 plus commercially approved drugs.
- Dr. Reddy settlement smooths the slope of Revlimid t0 2026 - probably more than made up by new indications
- Opdiva upside substantial given new clinical results off setting Ketruda lead  in lung cancer
- Pipeline blockbusters coming on stream, etc., etc.
-The combination, certainly offsetting some portion of legislative intervention on prescription drug pricing - a 15% impact on earnings still puts earnings at $5.50 which at a 14 P//E nets a high $70's stock price.
 
At some point, market and politics aside, BMY's PPS will reflect (my view) of reality - hopefully sooner than later.
 
Wall street is very fickle.  No wonder, Jim Cramer can be a star.
 
In the meantime, I continue to hold - a bit frustrated,  but sleeping well.
 
Good luck longs. 
 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 26     Views: 707
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
4316 Re: Hard to figure what Wall Street wants. Biotech2050 1 9/25/2020 9:29:44 AM






Financial Market Data provided by
.
Loading...